Latest Earnings Results: Q2 '26
Estimated EPS
$0.18
Reported EPS
$0.12
Surprise
-33.97%
Estimated Rev
$1.59B
Reported Rev
$1.62B
Surprise
+2.05%
• Reported GAAP EPS of $0.12 down -76.92% YoY • Reported revenue of $1.62B down -1.40% YoY • Ardent Health is reaffirming its full-year 2026 financial guidance, projecting total revenue between $6,400 million and $6,700 million and Adjusted EBITDA in the range of $485 million to $535 million.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.24 | -- | -- | N/A |
Q2 '26 | $0.18 | $0.12 | -33.97% | MISSED |
Q1 '26 | $0.19 | $0.28 | 46.73% | BEAT |
Q4 '25 | $0.32 | $0.32 | 1.04% | BEAT |
Q3 '25 | $0.42 | -$0.17 | -140.61% | MISSED |